The following list has been reviewed and approved by the European Society of Paediatric Radiology (ESPR)
Paediatric MSK |
Disease |
Biomarker and evidence for use |
Description of imaging technique |
Pathophysiological process informed by MRI biomarker |
Biomarker measured |
Units of measurement |
Suitable for use in clinical trials
|
Juvenile idiopathic arthritis (JIA) -synovial inflammation |
CE MRI1-3! |
T1 fs weighted images, pre- and post Gadolinium |
Key measure in grading synovitis |
Inflammation score |
0 - 3 |
Developmental dysplasia of the hip (DDH) |
US4! |
Coronal section through the mid-acetabulum (standard-view) |
Acetabular dysplasia
|
Alpha angle |
Degrees |
|
DDH |
XR5! |
Pelvic XR |
Acetabular dysplasia |
Acetabular Index Sharp’s angle Wiberg’s CE angle FHEI, ATD, ADR |
Degrees or mm |
|
Biomarkers in development |
DDH |
XR5! |
Pelvic XR |
Acetabular dysplasia |
Ogata angle Acetabular roof angle |
|
Coxarthrosis |
XR5! |
Pelvic XR |
Coxarthrosis |
Joint space width |
|
Neuro |
Disease |
Biomarker and evidence for use |
Description of imaging technique |
Pathophysiological process informed by MRI biomarker |
Biomarker measured |
Units of measurement |
Suitable for use in clinical trials |
Hydrocephalus |
US1! |
Coronal view through the 3rd ventricle |
Hydrocephalus |
Ventricular / SAS dimensions |
mm |
|
Disease |
Biomarker and evidence for use |
Description of imaging technique |
Pathophysiological process informed by MRI biomarker |
Biomarker measured |
Units of measurement |
Suitable for use in clinical trials
|
Physical abuse |
XR skeletal survey1! |
High-resolution radiographs |
Acute fracture of shafts of tubular bones, clavicles or ribs |
Soft tissue swelling No periosteal reaction or callus2,3! |
Number |
Physical abuse |
XR skeletal survey 1! |
High-resolution radiographs |
Healing fracture of shafts of tubular bones, clavicles or ribs |
Periosteal reaction, callus, or remodelling2,3! |
Number |
|
Physical abuse |
XR skeletal survey1! |
High-resolution radiographs |
Metaphyseal fracture ≤ 2 weeks of age4! |
Thickness4! |
mm (≤1mm) 4 |
|
Physical abuse |
XR skeletal survey1! |
High-resolution radiographs |
Metaphyseal fracture > 2 weeks of age4! |
Thickness4! |
mm (>1mm) 4 |
|
Physical abuse |
CT head1! |
Axial, coronal, sagittal and 3D recons (bone algorithm)1,5! |
Acute skull fracture (≤14 days) |
Overlying scalp swelling |
Presence/absence |
|
Abusive head injury |
CT or MRI1! |
RCR protocol1! |
Intracranial/spinal haemorrhage, hypoxic ischaemic injury6! |
Presence/absence |
Presence/absence |
Paediatric Oncology |
Disease |
Biomarker and evidence for use |
Description of imaging technique |
Pathophysiological process informed by MRI biomarker |
Biomarker measured |
Units of measurement |
Suitable for use in clinical trials |
Neuroblastoma |
ADC1-4! |
Diffusion weighted imaging |
Restriction of the free diffusibility correlates with histologic subtypes |
Diffusion restriction |
mm2/s |
Nephroblastoma |
ADC5-8! |
Diffusion weighted imaging |
Restriction of the free diffusibility correlates with histologic subtypes |
Diffusion restriction |
mm2/s |
|
Hodgkin Lymphoma |
Deauville Score9-11! |
18F-FDG-PET/CT |
18F-FDG Uptake after chemoth. correlates with outcome |
Points |
n.a. |
|
Neuroblastoma |
SIOPEN Score12,13! |
123I-metaiodobenzylguanidine scintigraphy |
Prognostic value of the SIOPEN skeletal score |
Points |
n.a. |
|
Neuroblastoma |
18F-FDG14-20! Uptake |
18F-FDG-PET/CT |
18F-FDG Uptake correlate with tumor grading |
SUV |
n.a. |
|
Brain tumor |
18F-FET Uptake21! |
18F-FET-PET/CT |
Brain tumor detection and recurrence |
SUV |
n.a. |
|
Solid tumor |
Tumor size22-25! RECIST 1.1 |
Cross sectional imaging |
Tumor dimension before and after chemotherapy correlates with outcome |
1 dimensional |
cm |
Paediatric Cardiac imaging |
Disease |
Biomarker and evidence for use |
Description of imaging technique |
Pathophysiological process informed by MRI biomarker |
Biomarker measured |
Units of measurement |
Suitable for use in clinical trials
|
Myocarditis |
Values of T1 native, T2 mapping and ECV in CMR in pediatric patients with myocarditis. |
CMR |
Myocardial inflamation |
CMR relaxation parameter T1 and T2
|
ms |
Normal values in pediatric healthy population |
- Normal values of diameter of Coronary Artery Diameters in pediatric population ( most of them with Congenital Heart Disease) , determined by Prospectively EKG- triggered coronary CT angiography (CCTA).
- Normal values of T1 native, T2 mapping and ECV in CMR in pediatric healthy population.
|
CCTA
CMR |
Diameter coronary arteries
Values in healthy pediatric population
|
Measure in orthogonal plane in coronary arteries
CMR relaxation parameter T1 and T2
|
Mm
ms |
|
Thalassaemia Major |
Value of T2* on CMR for the early identification and treatment of patients at high risk of heart failure and arrhythmia1! |
CMR (direct assessment of myocardial iron concentration with CMR because iron deposits shorten T2*) |
Myocardial siderosis |
CMR relaxation parameter T2* |
ms Cardiac T2* values > 20 ms are considered normal |
Paediatric lung imaging |
Disease |
Biomarker and evidence for use |
Description of radiology technique |
Pathophysiological process informed by biomarker |
Biomarker measured |
Units of measurement |
|
Cystic Fibrosis Bronchiectasis and airway wall thickening |
CT
|
End-inspiratory or free-breathing non-contrast enhanced CTR |
Key measure in disease progression1-4!, risk of pulmonary exacerbation3,5!, lower QoL |
Severity and extent of bronchiectasis
Airway Tapering |
Score depends on disease and scoring system6-7!: Semiquantitative (Bhalla, Brody, CF-CT), score range from 0-3 (mild-moderate-severe, tubular, varicose and cystic) Intra and inter branches tapering index |
Small Airways Diseases
|
CT |
End-expiratory CT |
Key measure in disease progression1,8,9!, reflecting small airways disease |
Low Attenuation Region (LAR) (LAR/Lungvolume)*100% |
Volume quantified with HU-based software or PRAGMA-CF scoring system7! |
|
Airways – artery ratio |
CT |
End-inspiratory of free-breathing CT non contrast enhanced |
Key measure of bronchiectasis, air wall thickening and lack of tapering |
Inflammation |
Automatic segmentation with software11,12, 13! Fraction of abnormal airways per generation |
|
PRAGMA-CF |
CT |
End-inspiratory and expiratory CT of free-breathing CT non contrast enhanced |
Measure of key CF features, such as bronchiectasis, bronchial wall thickening, mucus plugging, consolidation, air trapping |
Disease progression |
Each feature is express as % of total lung volume or ml |
|
Quantification of lung water |
MR |
Half-Fourier singleshot turbo spin-echo |
Measure the severity of lung disease or pulmonary oedema. |
Monitoring lung disease |
Lung water density (LWD, %) is the ratio of lung to liver signal intensity multiplied by 70%, the estimated hepatic water density16! |
|
Diaphragmatic motion disorders/Diaphragm hernia |
US/MRI |
M-mode sonography of hemidiaphragms during respiratory movements, subxiphoid and subcostal approach
T2- be used for clinical trials
Half-fourier-acqusition single-shot turbo spin-echo (HASTE) , T2- (true fast imaging with steady-state free precession) (TRUFI) at least two planes (coronal, axial or sagittal) |
Key measure in evaluation of hemidiaphragmatic respiratory movements
Key measure is to identify the diaphragm defect, hernia content, mediastinal shift, associated lung abnormalities |
Hemidiaphragmatic excursions, difference of excursions between the hemidiaphragms Severity and extent of the diaphragm defect |
mm, % 14,15!
mm, % |